Connect with us

Published

on

Elizabeth Holmes, founder of Theranos Inc., left, arrives at federal court in San Jose, California, on Tuesday, Oct. 12, 2021.
David Paul Morris | Bloomberg | Getty Images

SAN JOSE, CALIF. — A third juror was dismissed in Elizabeth Holmes’ criminal trial on Friday for what the judge said was “good cause.” That leaves only two alternates in a trial that’s expected to last until December.

U.S. District Court Judge Edward Davila told prosecutors and defense attorneys for Holmes that he received an email from juror No. 5 on Friday morning. The judge, along with Jeffrey Schenk, an assistant U.S. attorney, and Kevin Downey, a defense attorney for Holmes, spoke with the juror in chamber.

“The court had found good cause to excuse a juror,” Davila told the courtroom upon his return. There was no explanation given for excusing the female juror.

An alternate juror was selected to join the main bench. The impaneled jury deciding the fate of Holmes consists of eight men and four women.

“The juror raised the issue on their own, so they began to believe their ability to serve as an impartial juror was compromised,” said Danny Cevallos, an attorney and NBC News legal analyst, in an interview. “Apparently the court agreed with them,” said Cevallos, who’s been following the case but was not present in the courtroom.

Holmes’ high-profile trial began in San Jose seven weeks ago. The second juror was removed two weeks ago after revealing that, due to her Buddhist beliefs, she could not in good conscious return a verdict that may send Holmes to prison. Last month, a 19-year-old juror was dismissed for financial hardships.

Losing too many jurors runs the risk of a mistrial. However, Cevallos said that, according to a federal rule, after a jury has started deliberations a judge may permit a jury of 11 to return a verdict.

Holmes has pleaded not guilty to ten counts of wire fraud and two counts of conspiracy to commit wire fraud. Federal prosecutors allege Holmes and her co-conspirator, former company president Ramesh “Sunny” Balwani, engaged in a decade-long multimillion-dollar scheme to defraud investors and patients with regards to Theranos’ blood-testing technology.

Holmes and Balwani were indicted in 2018. Her trial has been delayed multiple times due to pandemic-related challenges and Holmes’ pregnancy. Balwani, who also pleaded not guilty, will face a separate trial next year.

Even in the case of a mistrial, Holmes would not be in the clear.

“A retrial, which the government certainly would do, would put Elizabeth’s life on hold again and drain her accounts even further,” Cevallos said. “So as much as a mistrial isn’t a conviction sometimes you’d rather get to the verdict.”

Skepticism from Pfizer

Following the juror’s departure, a scientist at Pfizer, Shane Weber, took the stand. Weber evaluated Theranos in 2008, and reviewed documents related to the blood-testing technology. He later concluded that Pfizer should not pursue a deal with the company.

In his December 2008 summary of a report, Weber recommended that “Theranos does not at this time have any diagnostic or clinical interest to Pfizer,” but he recommended the company revisit the matter every six months.

Weber’s report was shown to jurors. In it, Weber wrote, “Theranos has provided a poorly prepared summary document of their platform for home patient use with anti-angiogenic therapies.”

Further down, he wrote, “Theranos has provided non-informative, tangential, deflective or evasive answers to a written set of technical due diligence questions.”

Weber told his supervisors in an email in January 2009, that he spoke to Holmes to explain that Pfizer would not be using Theranos’ at-home products for patients.

“I was polite, clear, crisp and patiently firm as she pushed back,” the email said. “She asked for other names at Pfizer to approach and I politely deflected.”

Jurors were shown a version of a Theranos report that Holmes had sent to Walgreens executives with the Pfizer logo on it. Weber testified that Pfizer didn’t approve the use of its logo on the report.

“Would it be fair to say in 2010 or after that Pfizer endorsed Theranos technology?” Robert Leach, an assistant U.S. attorney, asked.

Weber responded, “Uh, no.”

Under cross-examination, Weber told jurors that his report on Theranos was never sent to Holmes.

‘Keep things under wraps’

Also on Friday, jurors heard from Bryan Tolbert, who made an investment in Theranos in 2006 and 2013 through Black Diamond Ventures. The firm, which was founded by by Chris Lucas, invested $5 million in the start-up.

Tolbert told jurors that there was limited information about Theranos at the time, but “it felt like a revolutionary technology and you wanted to preserve to your advantage.”

“Chris and I wanted more information, more financial information, more visibility about what was going on,” Tolbert said. “I certainly thought it was intentional they were trying to keep things under wraps.”

WATCH: Another Theranos insider testifies against founder Elizabeth Holmes

Continue Reading

Technology

Taiwan bans Chinese social media app RedNote for one year on fraud risks

Published

on

By

Taiwan bans Chinese social media app RedNote for one year on fraud risks

Dado Ruvic | Reuters

Taiwan on Thursday announced an immediate one-year ban on the Chinese social media network Xiaohongshu, saying the app posed a risk of fraud.

Taiwan’s interior ministry said in a statement that it will block access to Xiaohongshu, also known in English as Rednote, calling it a potential “high-risk area for online shopping fraud.”

Authorities linked the platform to about 1,700 fraud cases that caused financial losses of over 247.7 million New Taiwan dollars ($7.9 million) since 2024, the ministry said. The app has over 3 million users on the island, the ministry said.

Officials also said that Taiwanese law enforcement agencies face “significant difficulties” obtaining necessary information because Taiwan lacks jurisdiction over the company.

The interior ministry said the app failed all 15 indicators in cybersecurity tests conducted by the National Security Bureau.

Taiwan’s internet service providers were instructed to block access to the app, Deputy Minister of the Interior Ma Shih-yuan said in a press conference Thursday.

The ministry also urged international platforms such as Google to “completely cease publishing Xiaohongshu advertisements.”

Authorities reminded the public not to download the app or stop using it if already installed.

In a Facebook post, Cheng Li-wun, chairwoman of the opposition Kuomintang party, said the move “significantly [restricts] Internet freedom,” and described the ban on Xiaohongshu as “a starting-point for building the Great Wall of the Internet,” by the ruling Democratic Progressive Party.

Xiaohongshu, Apple and Google did not immediately respond to CNBC’s request for comments.

In 2022, Taiwan banned Xiaohongshu from government devices, calling it a “united front” for Chinese propaganda.

Earlier this year, Taiwan sent a letter to Xiaohongshu’s parent company, Xingyin Information Technology (Shanghai), seeking “concrete improvement measures,” but the company did not reply.

Xiaohongshu is widely used in China and saw renewed interest in the U.S. earlier this year after a proposed ban on its competitor TikTok. That prompted TikTok users to flock to Xiaohongshu, adding roughly 700,000 new users to the platform, according to Reuters.

— CNBC’s Anniek Bao contributed to this report.

Continue Reading

Technology

‘China’s Nvidia’ Moore Threads surges over 400% on trading debut after $1.1 billion listing

Published

on

By

'China's Nvidia' Moore Threads surges over 400% on trading debut after .1 billion listing

An illustration photo shows Moore Threads logo in a smartphone in Suqian, Jiangsu Province, China on October 30, 2025.

Cfoto | Future Publishing | Getty Images

Shares of Moore Threads, a Beijing-based graphics processing unit (GPU) manufacturer often referred to as “China’s Nvidia,” soared by more than 400% on its debut in Shanghai following its $1.1 billion listing.

The stock is currently trading at 584.98 yuan, over five times its IPO price of 114.28 yuan.

Moore Threads’ IPO was led by CITIC Securities, which served as the lead underwriter for the offering. The joint book runners on the deal were BOC International Securities, China Merchants Securities, and GF Securities.

The company, which is not yet profitable, said in its listing that the IPO proceeds are needed to accelerate several core research and development initiatives, including new-generation self-developed AI training and inference GPU chips. A portion of the funds will also be used to supplement working capital.

Moore Thread’s successful IPO comes despite it being placed under U.S. sanctions in 2023, which limited its access to advanced chip manufacturing processes and foundries.

The firm is representative of a growing cast of Chinese companies developing AI processors amid Beijing’s efforts to reduce reliance on American chip designer Nvidia.

Other companies in the space include tech giants like Huawei, as well as more specialized players like Cambricon — a firm whose shares on the Shanghai exchange have surged more than 100% year to date.

Washington has maintained varying export restrictions on Nvidia for years, preventing it from selling its most advanced AI chips to China. More recently, Beijing has also stepped in to block imports of Nvidia’s chips as it tries to encourage domestic alternatives like Moore Threads.

Newer players like Enflame Technology and Biren Technology have also entered the space, aiming to capture a share of the billions in GPU demand no longer served by Nvidia. Chinese regulators have also been clearing more semiconductor IPOs in their drive for greater AI independence.

What to know about Moore Threads, 'China’s Nvidia'

Continue Reading

Technology

SoFi’s stock drops on $1.5 billion share sale announcement

Published

on

By

SoFi's stock drops on .5 billion share sale announcement

Anthony Noto, CEO of SoFi, speaking with CNBC at the annual Allen & Co. Media and Technology Conference in Sun Valley, Idaho on July 10th, 2025.

David A. Grogan | CNBC

SoFi shares fell almost 6% in extended trading Thursday after the fintech company announced a $1.5 billion stock offering.

The company, which provides online loans and other banking services, said in a press release that it will use the proceeds for “general corporate purposes, including but not limited to enhancing capital position, increasing optionality and enabling further efficiency of capital management, and funding incremental growth and business opportunities.”

The announced offering comes after SoFi’s market cap almost doubled so far in 2025. The stock price is up more than sixfold since the end of 2022.

A company’s share price often drops on a planned share sale as the offering dilutes the value of existing holders’ stakes.

In its third-quarter earnings release in late October, SoFi reported revenue growth of 38% from a year earlier to $961.6 million, while net income more than doubled to $139.4 million. The company reported cash and equivalents of $3.25 billion.

WATCH: SoFi CEO on launch of crypto trading

SoFi CEO on launch of crypto trading: Blockchain and crypto are a supercycle technology just like AI

Continue Reading

Trending